Influenza Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

9 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1Oseltamivir PhosphateOseltamivir Phosphate · $3.03 per unit$18.7 million
  2. 2Promethazine HCl*Promethazine HCl · $0.23 per unit$13.2 million
  3. 3PrometheganPromethazine HCl · $5.04 per unit$1.9 million
  4. 4BenzonatateBenzonatate · $0.37 per unit$1.9 million
  5. 5Promethazine-DMPromethazine/Dextromethorphan · $0.05 per unit$130,222
  6. 6TamifluOseltamivir Phosphate · $9.65 per unit$56,462
  7. 7Brompheniramine-Pseudoephed-DMBrompheniramine/Pseudoephed/DM · $0.09 per unit$16,298
  8. 8Promethazine-CodeinePromethazine HCl/Codeine · $0.06 per unit$8,737
  9. 9PhenerganPromethazine HCl · $2.95 per unit$5,564

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Benchmarks on influenza

Countries side by side on public measures for this topic.

All benchmarks

US drug spending on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.